These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21725917)

  • 1. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
    Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
    J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
    Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
    Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
    Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
    Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation.
    Sjöberg B; Qureshi AR; Anderstam B; Alvestrand A; Bárány P
    Blood Purif; 2012; 34(3-4):290-7. PubMed ID: 23235124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease.
    Boehme M; Kaehne F; Kuehne A; Bernhardt W; Schröder M; Pommer W; Fischer C; Becker H; Müller C; Schindler R
    Nephrol Dial Transplant; 2007 Aug; 22(8):2224-9. PubMed ID: 17496115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein.
    Zhou Y; Ni Z; Zhang J; Zhang W; Wu Q; Shen G; Wang Y; Qian J
    Vasc Med; 2013 Apr; 18(2):85-91. PubMed ID: 23609129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
    Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
    QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients.
    Argani H; Ghorbanihaghjo A; Panahi G; Rashtchizadeh N; Safa J; Meimand SM
    Clin Biochem; 2012 Jul; 45(10-11):775-9. PubMed ID: 22546644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
    Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis.
    Savchenko AS; Inoue A; Ohashi R; Jiang S; Hasegawa G; Tanaka T; Hamakubo T; Kodama T; Aoyagi Y; Ushiki T; Naito M
    Pathol Int; 2011 May; 61(5):290-7. PubMed ID: 21501295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up.
    Zhou Y; Zhang J; Zhu M; Lu R; Wang Y; Ni Z
    Blood Purif; 2015; 39(4):266-73. PubMed ID: 25924996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: a cross-sectional study.
    Assa S; Hummel YM; Voors AA; Kuipers J; Westerhuis R; Groen H; Bakker SJ; Muller Kobold AC; van Oeveren W; Struck J; de Jong PE; Franssen CF
    Am J Kidney Dis; 2014 Aug; 64(2):265-73. PubMed ID: 24364893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in circulating biomarkers during a single hemodialysis session.
    Yamamoto T; Nascimento MM; Hayashi SY; Qureshi AR; Waniewski J; Brodin LÅ; Anderstam B; Lind B; Riella MC; Seeberger A; Lindholm B
    Hemodial Int; 2013 Jan; 17(1):59-66. PubMed ID: 22716238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
    Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
    J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
    McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
    Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris.
    Inoue K; Sugiyama A; Reid PC; Ito Y; Miyauchi K; Mukai S; Sagara M; Miyamoto K; Satoh H; Kohno I; Kurata T; Ota H; Mantovani A; Hamakubo T; Daida H; Kodama T
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):161-7. PubMed ID: 17095712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.